Alves G, Brønnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, Kurz MW, Andreasson U, Tysnes OB, Larsen JP, Mulugeta E. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1080-6. Epub 2010 Jun 14 PubMed.
AlzBiomarker Database
Meta-Analysis
- AD vs CTRL : Aβ38 (CSF)
- CTRL vs AD : Aβ38 (CSF)
- PD vs AD : Aβ38 (CSF)
- AD vs CTRL : Aβ40 (CSF)
- CTRL vs AD : Aβ40 (CSF)
- PD vs AD : Aβ40 (CSF)
- AD vs CTRL : Aβ42 (CSF)
- CTRL vs AD : Aβ42 (CSF)
- PD vs AD : Aβ42 (CSF)
- AD vs CTRL : tau-p181 (CSF)
- CTRL vs AD : tau-p181 (CSF)
- PD vs AD : tau-p181 (CSF)
- AD vs CTRL : tau-total (CSF)
- CTRL vs AD : tau-total (CSF)
- PD vs AD : tau-total (CSF)
Curated Study Data
Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
---|---|---|---|---|
Aβ38 (CSF) |
AD (20) |
514 ± 267 pg/mL |
Electrochemiluminescence; MSD 4G8; Meso Scale Discovery |
McKhann et al., 1984 |
Aβ38 (CSF) |
CTRL- CNC (36) |
629 ± 332 pg/mL |
Electrochemiluminescence; MSD 4G8; Meso Scale Discovery |
|
Aβ38 (CSF) |
PD (109) |
484 ± 328 pg/mL |
Electrochemiluminescence; MSD 4G8; Meso Scale Discovery |
Gelb et al., 1999 |
Aβ40 (CSF) |
AD (20) |
6104 ± 1505 pg/mL |
Electrochemiluminescence; MSD 4G8; Meso Scale Discovery |
McKhann et al., 1984 |
Aβ40 (CSF) |
CTRL- CNC (36) |
7070 ± 2432 pg/mL |
Electrochemiluminescence; MSD 4G8; Meso Scale Discovery |
|
Aβ40 (CSF) |
PD (109) |
5973 ± 2265 pg/mL |
Electrochemiluminescence; MSD 4G8; Meso Scale Discovery |
Gelb et al., 1999 |
Aβ42 (CSF) |
AD (20) |
208 ± 78 pg/mL |
Electrochemiluminescence; MSD 4G8; Meso Scale Discovery |
McKhann et al., 1984 |
Aβ42 (CSF) |
CTRL- CNC (36) |
445 ± 223 pg/mL |
Electrochemiluminescence; MSD 4G8; Meso Scale Discovery |
|
Aβ42 (CSF) |
PD (109) |
362 ± 192 pg/mL |
Electrochemiluminescence; MSD 4G8; Meso Scale Discovery |
Gelb et al., 1999 |
tau-p181 (CSF) |
AD (20) |
89 ± 36 pg/mL |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
tau-p181 (CSF) |
CTRL- CNC (36) |
51 ± 23 pg/mL |
ELISA; Innotest; Innogenetics |
|
tau-p181 (CSF) |
PD (109) |
58 ± 38 pg/mL |
ELISA; Innotest; Innogenetics |
Gelb et al., 1999 |
tau-total (CSF) |
AD (20) |
435 ± 217 pg/mL |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
tau-total (CSF) |
CTRL- CNC (36) |
228 ± 110 pg/mL |
ELISA; Innotest; Innogenetics |
|
tau-total (CSF) |
PD (109) |
224 ± 117 pg/mL |
ELISA; Innotest; Innogenetics |
Gelb et al., 1999 |
Recommends
Please login to recommend the paper.
This paper appears in the following:
News
AlzBiomarker
- AD vs CTRL : Aβ38 (CSF)
- CTRL vs AD : Aβ38 (CSF)
- PD vs AD : Aβ38 (CSF)
- AD vs CTRL : Aβ40 (CSF)
- CTRL vs AD : Aβ40 (CSF)
- PD vs AD : Aβ40 (CSF)
- AD vs CTRL : Aβ42 (CSF)
- CTRL vs AD : Aβ42 (CSF)
- PD vs AD : Aβ42 (CSF)
- AD vs CTRL : tau-p181 (CSF)
- CTRL vs AD : tau-p181 (CSF)
- PD vs AD : tau-p181 (CSF)
- AD vs CTRL : tau-total (CSF)
- CTRL vs AD : tau-total (CSF)
- PD vs AD : tau-total (CSF)
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.